A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis
Authors
Keywords
Noptosis, Glioblastoma, Tanshindiol B, NQO1, JNK1/2
Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 166, Issue -, Pages 104-115
Publisher
Elsevier BV
Online
2021-02-16
DOI
10.1016/j.freeradbiomed.2021.02.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1)
- (2020) Jie Yu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds
- (2020) Jie Yu et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer
- (2020) Colton L. Starcher et al. Frontiers in Oncology
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis
- (2019) Cristina Florean et al. FREE RADICAL BIOLOGY AND MEDICINE
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms
- (2019) Sarah K. Beaver et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
- (2019) Bernd Kaina et al. DNA REPAIR
- The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death
- (2019) Evgeniia A. Prokhorova et al. ONCOGENE
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
- (2019) Braicu et al. Cancers
- Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells
- (2019) Xin Liu et al. BIOCHEMICAL PHARMACOLOGY
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
- (2018) Kuojun Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
- (2018) David E. Gerber et al. BRITISH JOURNAL OF CANCER
- Necroptotic cell death in anti-cancer therapy
- (2017) Olga Krysko et al. IMMUNOLOGICAL REVIEWS
- Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
- (2017) Muhammad Shaalan Beg et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
- (2017) Meiying Ji et al. Oncology Letters
- Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
- (2016) Xiumei Huang et al. CANCER CELL
- Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in Rats
- (2015) Iksoo Kim et al. Biomolecules & Therapeutics
- Implications of NQO1 in cancer therapy
- (2015) Eun-Taex Oh et al. BMB Reports
- High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
- (2015) Xuelian Cui et al. BMC CANCER
- Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells
- (2015) Guowen Ren et al. Journal of Natural Medicines
- Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers
- (2014) Lifen Cao et al. ANTIOXIDANTS & REDOX SIGNALING
- Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors
- (2014) Jimin Woo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Clinical implications of high NQO1 expression in breast cancers
- (2014) Yang Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic Review
- (2013) Xiuping Chen et al. MEDICINAL RESEARCH REVIEWS
- Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT
- (2012) G. Jiang et al. CURRENT MEDICINAL CHEMISTRY
- Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of -Lapachone for Pancreatic Cancer Therapy
- (2011) L. S. Li et al. CLINICAL CANCER RESEARCH
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started